The episode focuses on three stocks--Humana, Merck, and Dollar Tree--that have proven they can climb during 2022's falling market and operate businesses that are likely to withstand any economic downturn or possible recession.
Globus Medical's (GMED) Musculoskeletal Solutions products generate solid revenues on growth in spine and trauma implant portfolios.
PacBio (PACB) sees strength in Q2 segmental revenues, led by robust consumable and instrument sales.